contraceptive pills_AS_247x165

Independent professional body guideline

FSRH CHC guideline


This concise updated summary of the FRSH combined hormonal contraception guideline covers use, effectiveness, non-contraceptive benefits, and risks

contraceptive methods_254409397_JPC-PROD

Independent professional body guideline

FSRH overweight, obesity, and contraception guideline


Covering evidence-based recommendations on the provision of contraception to women who are overweight or obese


Independent professional body guideline

BSPID/EFP oral health and pregnancy guideline

2021-06-25T08:07:00+01:00By British Society of Periodontology and Implant Dentistry, European Federation of Periodontology

A short, useful summary of key oral health recommendations for pregnant women from the British Society of Periodontology

hands holding pills

Independent professional body guideline

FSRH emergency contraception guideline


This summary of FSRH EC guidance compares the effectiveness of EC methods and decision-making based on patients’ needs, including helpful algorithms.

urine infection

SIGN guideline

SIGN guideline on bacterial UTIs in women


This guidance provides advice on the managment of suspected bacterial lower urinary tract infection in adult women


Independent professional body guideline

FSRH UKMEC contraception guideline


A summary of the FSRH UKMEC guidance on the safety of contraceptive methods, which is set out in clear and concise tables.


NICE guideline

NICE CKS candida—female genital


This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting.

Doctor explaining diagnosis to woman pointing at laptop

NICE guideline

NICE menopause guideline


This summary covers diagnosis, treatment options, and includes a useful care algorithm for the management of menopause.

Doctor In Consultation With Female Patient In Office

NICE guideline

NICE recommendations for women with urinary incontinence


Summary of NICE guidance covers history taking, assessing urinary incontinence, investigations, non-surgical management, and indicators for referral

Female doctor with lady patient_AS206x137

Working party guideline/algorithm

Uncomplicated recurrent UTI guideline

2019-03-19T09:07:00+00:00By Working party—Rees Brocksom Harding Jacobson Rollinson

This guideline was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from Aspire Pharma Ltd.

Resource hub

  • Making the case for preconception care

  • Having a smear test—what is it about?

  • Human papillomavirus (HPV) vaccination and cervical cancer—addressing the myths

  • Your guide to staying active in pregnancy

  • Pain and symptom diary

Educational resources

20210930_HRT prescribing supplement

Prescribing hormone replacement therapy (HRT) in postmenopausal women: a focus on Oestrogel® (estradiol) and Utrogestan® 100 mg (micronised progesterone)

Commissioned by Besins Healthcare (UK) Ltd

This prescribing supplement has been commissioned and funded by Besins Healthcare (UK) Ltd and developed in partnership with Guidelines. Includes promotional information.
View prescribing and adverse event reporting information
OES/2021/001a October 2021
For healthcare professionals only.

Viatris HRT algorithm supplement_Index image

Prescribing combined hormone replacement therapy (HRT) containing dydrogesterone

Commissioned by Viatris

This promotional algorithm has been commissioned and funded by Viatris and developed in partnership with Guidelines. Intended for UK healthcare professionals.
View Femoston® (estradiol/dydrogesterone) and Femoston® -conti (estradiol/dydrogesterone) prescribing and adverse event reporting information.
FEM-2021-0238 June 2021

X-ray (female pelvis) 397x302

Osteoporotic fracture guideline

By Working party—Cooper Javaid Elliott Stephens Tanna

This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of an educational grant from UCB Pharma Ltd.

Preconception advice

Women of child-bearing age with inflammatory rheumatic diseases guideline

By Working party—Giles Allen Nelson-Piercy Tower Warburton Gordon

This guideline was developed by a multidisciplinary expert panel: Giles I et al with the support of an educational grant from UCB Pharma Ltd.

Mylan HRT evidence update cover

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.